Boston Scientific Corporation (BSX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Boston Scientific Corporation  (NYSE: BSX)


Boston Scientific's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Boston Scientific's ROI in the third quarter of 2026?
Boston Scientific Corporation achieved a return on average invested assets (ROI) of 9.2 % in its third quarter of 2026, this is above BSX's average return on investment of 0.68%.
Boston Scientific Corporations investments during the 12 months ending in the third quarter of 2026 are valued at $37 billion

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 61 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 803, from total ROI ranking in the second quarter of 2026 at 1142.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 13.9 % 14.24 % 14.01 % 13.68 % 12.5 %
Y / Y Net Income Change TTM 25.46 % 46.88 % 108.98 % 180.5 % 495.09 %
Investment (TTM) in Millions 39,722 39,030 37,332 35,848 34,983
Return On Investment (TTM) 9.2 % 9.97 % 10.01 % 8.38 % 8.35 %
BSX's Overall Ranking # 803 # 1142 # 918 # 956 # 1122
Seq. Investment Change TTM 3.22 % 3.54 % 2.99 % 3.48 % 3.53 %
Seq. Net Income Change TTM -4.77 % 3.09 % 23.06 % 3.84 % 11.49 %
Net Income (TTM) in Millions 3,494 3,669 3,559 2,892 2,785

BSX Company Profile >> Back to BSX Roi Comparisons >> See Annual BSX Return On Investment



Return On Investment BSX's Ranking
Within: No.
Industry # 19
Sector # 62
Overall # 803

Return On Investment Statistics
High Average Low
22.36 %
0.68 %
-31.45 %
(Dec 31 2019)   (June 30, 2006)







Financial Statements
Boston Scientific's III. Quarter Investments $ 39,722 Millions BSX's Balance sheet
Boston Scientific's III. Quarter Income $ 580 Millions Quarterly BSX's Income Statement
BSX's Income by Division See BSX's Income by Division


BSX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 35,848 31,204 28,349 26,488 27,955
Y / Y Investment Growth 14.88 % 10.07 % 7.03 % -5.25 % 3.17 %
Net Income in Millions 2,892 1,846 1,592 698 1,041
Y / Y Net Income Growth 56.66 % 15.95 % 128.08 % -32.95 % -
Annual Return On Investment 8.07 % 5.92 % 5.62 % 2.64 % 3.72 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 8.07 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BSX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BSX's Competitors
Subscribers only: Roi for Boston Scientific's Suppliers
Subscribers only: Return On Investment for BSX's Customers

Other Ratios
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Statistics
BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %

Date modified: 2026-11-03T09:56:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.